The company is not liable for any loss or injury resulting from reliance on information provided by guests in these videos.Viewers are encouraged to use their own judgment and discretion when interpreting the content presented and to seek professional advice or conduct independent research to verify its accuracy and relevance.By viewing these videos, you agree to indemnify and hold EllieMD, its employees, agents, and affiliates harmless from any legal claims or actions arising from the content of the interviews.This disclaimer is subject to change without notice, and viewers are advised to check for updates regularly.#EllieMD #PeptideTherapy #RealStories #CustomerJourney #LongevitySupport #GHKCu #BPC157 #HealthyAging #WellnessTransformation #EllieCommunity Fueling Your GLP-1 Journey with Fitness & Protein | Featuring Jon Luckey In this episode of EllieMDs Educational Series, fitness coach and transformation expert Jon Luckey shares how to optimize your results on GLP-1 medications through strategic fitness, smart nutrition, and daily protein support

Markers community sources associate with a working protocol: Sleep quality improved within the first 1-2 weeks IGF-1 increased 20-40%+ from baseline at 4-6 week bloodwork Gradual improvements in recovery, skin quality, or body composition by weeks 6-8 Mild, transient side effects (slight water retention, occasional joint stiffness) that resolve Patterns community sources describe before discontinuing: No sleep improvement after 2 weeks community sources describe verifying fasted injection timing and peptide source quality IGF-1 unchanged at 4-6 weeks community protocols describe increasing to twice-daily dosing (300 mcg AM + PM) or evaluating peptide authenticity Persistent water retention or joint pain beyond week 3 community sources interpret this as a dose running too high and describe reducing to 200 mcg Signals community and clinical sources associate with stopping: Persistent numbness or tingling in extremities (potential carpal tunnel from excessive GH) Blood glucose consistently elevated on follow-up labs Any signs of abnormal growth or tissue changes documented guidance is to discontinue and consult a physician For detailed protocol parameters, see the ipamorelin dosing guide

Minimum requirements include purity assessment (HPLC), identity confirmation (mass spectrometry), and endotoxin testing (LAL test)
2018 Aug ;51(5):199-209
Conventional corticosteroids, disease-modifying anti-rheumatic medications (DMARDs), such as methotrexate and hydroxychloroquine, non-steroidal antirheumatic drugs (NSAIDs), such as indomethacin, ibuprofen, aspirin, etc., and immunosuppressive agents like TNF- and IL-6 inhibitors, are presently included in the treatment regime 9,11,12,13,14,15
We offer both individually, as a combo pack, and as a pre-blended vial